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Abstract 
The liver is recognised as a potential target site for nanoparticle (NP) toxicity, as 
NPs have been observed to accumulate within this organ subsequent to 
exposure via injection, inhalation or instillation.  The liver’s unique structure has 
to be taken into consideration when evaluating NP toxicity, as a variety of cell 
types of distinct morphology and function are evident, and potentially affected 
by NP exposure.  Of particular interest are hepatocytes, due to their abundance 
and importance to the maintenance of normal liver function, and macrophages 
due to their role in host defence.   
 
The uptake and intracellular fate of fluorescent polystyrene particles (20nm and 
200nm) by hepatocytes was evaluated (with exposure times of up to 60 
minutes).  Within the studies conducted comparisons of the response of primary 
rat hepatocytes, with C3A and HepG2 hepatocyte cell lines to NP exposure 
were made in order to investigate whether cell lines are a relevant model of 
hepatocyte behaviour.  It was found that the uptake of particles by the primary 
hepatocytes, and both cell lines was size and time dependent.  Specifically, it 
appeared that the internalisation of 200nm particles was limited, occurred at 
later time points (60 minutes), with the majority of particles evident at the cell 
surface.  Polystyrene NPs (20nm) were internalised by cells after a 10 minute 
exposure time, after which NPs compartmentalised either within and/or between 
adjacent cells.  The nature of the NP ‘compartments’, and therefore fate of 
internalised NPs was then investigated to determine if the compartments 
developed as a consequence of the mechanism of uptake, or due to the 
attempted elimination of NPs from cells.  It was found that NPs were not 
contained within early endosomes or lysosomes.  However it was apparent that 
polystyrene NPs were eliminated to a limited extent within the bile canaliculi of 
all cell types, and may accumulate within the mitochondria of cell lines after a 
60 minute exposure, which warrants further investigation. 
 
The impact of the PARTICLE_RISK particle panel [consisting of ultrafine carbon 
black (ufCB), CB, carbon nanotubes (CNTs), C60 (carbon fullerene) QD621 
(positively charged quantum dots) and QD620 (negatively charged quantum 
dots)] on hepatocyte function was then determined.  It was consistently 
observed that QD621 and QD620 were able to elicit the greatest extent of 
  
toxicity, evidenced within their ability to deplete cellular GSH, induce 
cytotoxicity, initiate a pro-inflammatory response (indicated by an increase in IL-
8 production) and decrease bile secretion, in the hepatocyte couplet, in vitro 
model.  It was observed that the pattern of response was similar within the cell 
lines and primary cells. 
 
Differentiated monocytic THP-1 cells (to represent the resident liver 
macrophages, Kupffer cells) were exposed to the PARTICLE_RISK particle 
panel to obtain conditioned medium (CM) that was exposed to hepatocytes, in 
order to gain insight into the ability of macrophages to influence NP mediated 
toxicity to hepatocytes.  Firstly, the response of macrophages to particle 
exposure was considered and it was apparent that the toxicity that was 
observed within hepatocytes was paralleled within the response of differentiated 
monocytic cells (THP-1).  Accordingly, QD621 were again proven to have the 
greatest toxic potential, with QD620 able to induce toxicity to a more limited 
extent.  The exposure of hepatocytes to CM potentiated the toxicity observed 
when cells were exposed to particles alone, so that the pattern of response was 
comparable, but the extent of toxicity greater, and evident at earlier time points.  
It was apparent that QDs were able to induce an inflammatory response 
(characterised by TNFα and IL-8 production) within the liver that was primarily 
mediated by macrophages.   
 
When considering the results from all experiments it is evident that some of the 
particles contained within the PARTICLE_RISK panel were more capable of 
eliciting toxicity within the liver, and that their toxicity can be ranked in the 
following order: QD621>QD620>CNT=ufCB=C60>CB. 
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A supplementary data DVD has been provided that contains animations 
associated with the following figures: 
 
 
Figure 4.6.  Confirming the uptake of 20 or 200nm polystyrene particles by 
C3A cells using Z stacks     
 
  
Figure 4.7.  The live imaging of fluorescent polystyrene particle uptake (20nm 
and 200nm) by C3A and HepG2 cells, in the presence and 
absence of serum   
 
•If the speed of the animations is too fast within the z stacks featured within 
figure 4.6, then I recommend pausing the movie, and using the ‘clip position’ 
tool to move through the different optical slices of the image. 
 
•The z stacks were also converted into 3D projections, which can also be 
viewed within the supplementary DVD.  
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Abbreviations 
α   alpha 
AFM  atomic force microscopy 
ARE   antioxidant response element 
ATP   adenosine triphosphate 
ß   beta 
BSA   bovine serum albumin 
BSP   bromosulphophthalein 
C60   carbon fullerene 
Ca   calcium 
CaCl2   calcium chloride 
CB   carbon black 
CCl4   carbon tetrachloride 
CdSe   cadmium selenide 
CdTe   cadmium telluride 
CM   conditioned medium  
CME   clathrin mediated endocytosis  
CNT   carbon nanotube 
CO2   carbon dioxide 
COPD   chronic obstructive pulmonary disease 
CLF   cholyl lysyl fluorescein 
CVA   canalicular vacuole accumulation 
CYP450 cytochrome P450 
dH2O   distilled water 
DCFH   dichlorofluorescin  
DCFH-DA 2,7-dichlorofluorescein diacetate 
DLS  dynamic light scattering  
DNA   deoxyribonucleic acid 
DEP   diesel exhaust particles 
DPPC  dipalmitoylphosphatidylcholine 
DTT  dithiothreitol 
ECV   endosomal carrier vesicle 
EDTA   ethylenediaminetetraacetic acid 
EEA-1   early endosome antigen 1 
ELISA   enzyme linked immunosorbant assay 
EM  electron microscopy 
ER   endoplasmic reticulum 
FCS   fetal calf serum 
FFF  field flow fractionation 
  
Abbreviations (continued) 
GIT   gastroIntestinal tract 
H2SO4   sulphuric acid 
HBSS   hanks balanced salt solution 
HO-1   heme oxygenase 
Hr   hour 
HPLC-MS  high performance liquid chromatography  
HRP   horse radish peroxidise 
ICP-MS  inductively coupled plasma mass spectroscopy  
i.t   intra-tracheal 
i.v.  intravenous 
IRHC   isolated rat hepatocyte couplet 
IL   interleukin 
LCD   liquid crystal display 
LAMP-1  lysosome associated protein 1 
M   molar 
m   metre 
MEM  minimum essential medium 
mins   minutes 
ml   millilitre 
mM   millimolar 
mRNA  messenger ribonucleic acid 
MTT   2-(4,5-dimethyl-2-thiazolyl)-3,5-diphenyl- 2H-tetrazolium bromide 
MgCl2   magnesium chloride 
MWCNTS  multi walled carbon nanotubes 
MRP2   multridrug resistant protein 2 
mm   millimetre 
NaCl   sodium chloride 
NaOH  sodium hydroxide 
Na/K ATPase sodium/potassium pump 
NADH   β-nicotinamide adenine dinucleotide 
NF- kß  nuclear factor kappa beta  
NADPH  nicotinamide adenine dinucleotide phosphate 
NEM  N-Ethylmaleimide 
nm   nanometre 
NP   nanoparticle 
NO   nitric oxide 
OPT   o-phthaldialdehyde  
PAH  polycyclic aromatic hydrocarbons 
  
Abbreviations (continued) 
PBS   phosphate buffered saline 
PEG   polyethylene glycol  
Pen/Strep  penicillin streptomycin 
PM   plasma membrane 
PMA   phorbyl myristate acetate 
POC-R perfusion, open and closed cultivation 
P-gp   p-glycoprotein 
QD   quantum dot 
RBC   red blood cell 
RES   reticuloendothelial system 
ROS   reactive oxygen species 
SA   surface area 
SARs  structure activity relationships 
SEM   scanning electron microscopy 
Strep-PE  streptavadin phycoerythrin 
SWCNTS  single walled carbon nanotubes 
TEM   transmission electron microscopy 
TNF   tumour necrosis factor  
TiO2   titanium dioxide 
UV   ultraviolet 
UVR   ultraviolet radiation 
ufCB   ultrafine carbon black 
w/o   without 
ZnS   zinc sulphide 
4HNE   4 hydroxynoneal 
8-O-H-G  8hydroxyguanosine 
µg  microgram  
µl   microlitre 
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